🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several professionals said the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Removal

Based on the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.

After moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.

Item Information and Costs

Inside these groups, messages display black plastic packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Although the research behind retatrutide is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.